Disc Medicine Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Disc Medicine stock has a consensus rating of "Strong Buy" and an average price target of $125.75. The average 1-year stock price forecast is 57.38% higher than the current stock price, while the lowest is $92 (+15.14%) and the highest is $170 (+112.77%).

Price Target: $125.75 (+57.38%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$92	$125.75	$122	$170
Change	+15.14%	+57.38%	+52.69%	+112.77%

Analyst Ratings

The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	12	12	12	12	12	12
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Smith Leerink Partners	Leerink Partners	Buy Reiterates $100 → $130	Buy	Reiterates	$100 → $130	+62.70%	Oct 27, 2026
Sean Laaman Morgan Stanley	Morgan Stanley	Buy Reiterates $90 → $92	Buy	Reiterates	$90 → $92	+15.14%	Oct 20, 2026
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $125 → $170	Buy	Reiterates	$125 → $170	+112.77%	Oct 20, 2026
Danielle Brill Truist Financial	Truist Financial	Buy Maintains $83 → $115	Buy	Maintains	$83 → $115	+43.93%	Oct 19, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $100 → $130	Buy	Maintains	$100 → $130	+62.70%	Oct 19, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

32.67M

EPS This Year

-6.55

from -6.01

EPS Next Year

-6.82

from -6.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-30.93M	-47.48M	-91.13M	-129.72M	-235.17M	-280.58M
Net Income	-35.97M	-46.83M	-76.43M	-109.36M	-212.18M	-263.51M
EPS	-	-	-	-	-6.01	-6.55
Free Cash Flow	-	-	-	-	-181.33M	-232.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-5.40
Avg	-6.55
Low	-7.24

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-